Renal anemia is a common complication of chronic renal failure caused by erythropoietin deficiency; targeting erythropoietin is a common approach to renal anemia treatment. This paper describes the role of erythropoietin and others drugs in renal anemia treatment, as well as the cause of erythropoietin resistance.Keywords: Chronic renal failure, Renal anemia, Erythropoietin resistanc
Introduction: Anemia is most commonly associated with chronic kidney disease. In CKD patients, anemi...
The administration of recombinant human erythropoietin (EPO) has considerably improved renal anemia ...
Erythropoietin (EPO) is a haematopoietic cytokine, mainly generated in the renal cortex, and its sec...
Hyporegenerative anaemia is common complication of chronic renal failure CRF and responsible for fat...
This thesis is concerned with a study of the clinical and biological effects of recombinant human er...
Recombinant Human erythropoietin (RhEpo) has become an important discovery in the medical world rela...
Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure.BackgroundThe anemi...
Background: The worldwide rise in the number of patients with chronic renal failure (CRF). Chronic R...
Erythropoietin, produced primarily by the kidneys, is the principal factor responsible for the regul...
The human recombinant erythropoietin (hrEpo) is crucial in anemia treatment options in chronic renal...
Nearly two decades ago, recombinant human erythropoietin transformed the management of chronic kidne...
Anaemia become the complication of chronic kidney disease (CKD) which was caused by decreasing of er...
Anemia (hematocrit < 25%) predictably accompanies chronic renal failure and is present in over 90...
Anemia management and chronic renal failure progression Analysis of the biologic effects of erythrop...
PBackground and Aim: Routine clinical and laboratory assessments facilitate the diagnosis of erythro...
Introduction: Anemia is most commonly associated with chronic kidney disease. In CKD patients, anemi...
The administration of recombinant human erythropoietin (EPO) has considerably improved renal anemia ...
Erythropoietin (EPO) is a haematopoietic cytokine, mainly generated in the renal cortex, and its sec...
Hyporegenerative anaemia is common complication of chronic renal failure CRF and responsible for fat...
This thesis is concerned with a study of the clinical and biological effects of recombinant human er...
Recombinant Human erythropoietin (RhEpo) has become an important discovery in the medical world rela...
Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure.BackgroundThe anemi...
Background: The worldwide rise in the number of patients with chronic renal failure (CRF). Chronic R...
Erythropoietin, produced primarily by the kidneys, is the principal factor responsible for the regul...
The human recombinant erythropoietin (hrEpo) is crucial in anemia treatment options in chronic renal...
Nearly two decades ago, recombinant human erythropoietin transformed the management of chronic kidne...
Anaemia become the complication of chronic kidney disease (CKD) which was caused by decreasing of er...
Anemia (hematocrit < 25%) predictably accompanies chronic renal failure and is present in over 90...
Anemia management and chronic renal failure progression Analysis of the biologic effects of erythrop...
PBackground and Aim: Routine clinical and laboratory assessments facilitate the diagnosis of erythro...
Introduction: Anemia is most commonly associated with chronic kidney disease. In CKD patients, anemi...
The administration of recombinant human erythropoietin (EPO) has considerably improved renal anemia ...
Erythropoietin (EPO) is a haematopoietic cytokine, mainly generated in the renal cortex, and its sec...
DOI
Add to ORKG